As a control, we compared GBM cells against lymphocytes taken from peripheral blood of healthy individuals and fibroblasts previously used in the study by Maccaroni et al., 2020 to analyze the tissue-specific responses to APH treatment. This evidence concerns the gene APEH and glioblastoma.